CARDINAL HEALTH, INC.

Cardinal Health, Inc. is a publicly traded company listed on the New York Stock Exchange, and its shareholder base is governed by SEC beneficial-ownership disclosure rules rather than a state-level shareholder register; the Ohio Secretary of State does not maintain or publish shareholder records for the company. The institutional fund holdings shown in this profile reflect individual funds affiliated with large asset managers, each holding a low single-digit percentage of outstanding shares, consistent with a widely held large-cap stock rather than a concentrated ownership structure.

Institutional investors that have filed Schedule 13G beneficial-ownership statements with the SEC include Vanguard Capital Management, which reported holding 17,635,857 shares (7.49% of the class) as of 31 March 2026; Vanguard Portfolio Management, which reported holding 13,786,683 shares (5.85% of the class) as of 31 March 2026, following an internal realignment of Vanguard’s US investment advisers completed in January 2026; and Wellington Management Group LLP, which reported holding 14,860,271 shares (6.34% of the class) as of 30 June 2026. These are passive institutional positions rather than controlling stakes.

No ultimate beneficial owner can be identified for Cardinal Health, Inc. The company’s shares are widely held across numerous institutional and individual investors, and no natural person has been reported as beneficially owning shares at a level that would meet SEC disclosure thresholds.

Shareholder disclosure for Cardinal Health, Inc. should be considered major shareholders only: under SEC rules, only holders whose stakes cross the 5% reporting threshold are required to file beneficial-ownership statements, so the complete shareholder base is not publicly available. The information above is current as of the filing dates stated for each holder.

Cardinal Health, Inc.’s executive leadership and board of directors are disclosed through its filings with the U.S. Securities and Exchange Commission rather than through the Ohio Secretary of State’s corporate register, which does not publish a current executive-officer roster for the company. At its annual shareholders meeting in November 2025, shareholders elected a 12-member board of directors, including Robert W. Azelby, Michelle M. Brennan and Sheri H. Edison, to serve until the 2026 annual meeting.

Jason M. Hollar has served as Chief Executive Officer and a director of Cardinal Health, Inc. since January 2022, having previously served as the company’s Chief Financial Officer from 2020 to 2022. Aaron E. Alt has served as Chief Financial Officer since February 2023, having previously held the equivalent role at Sysco Corporation and at Sally Beauty Holdings.

In March 2026, Cardinal Health, Inc. announced that Patricia A. Hemingway Hall, a director since 2013 and former President and Chief Executive Officer of Health Care Service Corporation, would become Board Chair, succeeding Gregory B. Kenny, who had chaired the board since 2018.

The individual names and roles recorded with the Ohio Secretary of State relate to corporate officers and authorized signatories filed for state purposes, which is a separate disclosure regime from the executive and board appointments reported to the SEC; the two need not describe the same set of roles. Nationality and country of residence are not disclosed for any officer or director in the available public records.

Cardinal Health, Inc. is not owned or controlled by any parent company. It is an independent, publicly traded corporation listed on the New York Stock Exchange and sits at the top of its own corporate group.

According to the list of subsidiaries filed as an exhibit to its Form 10-K annual report with the SEC, Cardinal Health, Inc. has a large number of majority-owned subsidiaries incorporated across numerous U.S. states and in other countries, including Brazil, Canada, Denmark, Finland, France, Germany, India, Japan, Malaysia, Malta, Mexico, the Philippines and South Korea, reflecting the international scope of its pharmaceutical and medical-products distribution and manufacturing operations.

Group-structure information for Cardinal Health, Inc. is full at the parent level and partial at the subsidiary level: SEC filings confirm the company has no parent and identify its significant subsidiaries, but ownership percentages for individual subsidiaries are not separately disclosed in a single public source, and the more granular subsidiary list associated with this profile is compiled from linked corporate registrations rather than one official register.